Status: Recruiting
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Prospective, uncontrolled, investigator-initiated, phase II clinical study to explore the activity of trabectedin in a population of patients aged ≥16 years with progressive, advanced (locally advanced or metastatic)
Participants needed: 16
Trial details
Phase: Phase 2Age: 16+Biological sex: AllType: InterventionalSponsor: Italian Sarcoma GroupUpdated: Mar 27, 2026Locations: 7
Eligibility criteria
Age ≥ 16 years old [+13]
Other primary malignancy with <5 years clinically assessed disease free interval... [+16]